Clinical Trials Logo

Other Cancers clinical trials

View clinical trials related to Other Cancers.

Filter by:
  • Completed  
  • Page 1

NCT ID: NCT03146520 Completed - Healthy Clinical Trials

Clinical Validation of Stool DNA-based SDC2 Methylation Test for Colorectal Cancer Detection

Start date: December 13, 2016
Phase:
Study type: Observational

Pivotal trials of SDC2 methylation biomarker test in stool DNA to estimate clinical sensitivity and specificity in detection of colorectal cancer.

NCT ID: NCT02540850 Completed - Colorectal Cancer Clinical Trials

CRC Screening Using mSEPT9 (Methylated Septin 9) in Chinese Population

RESEPT
Start date: February 2014
Phase: N/A
Study type: Observational

The purpose of this study is to evaluate the performance of the SEPT9 gene methylation assay in Colorectal cancer (CRC) high-risk population in Chinese hospitals using the opportunistic screening method. The trial plans to evaluate a Chinese domestic SEPT9 assay kit produced by BioChain (Beijing) Science and Technology Corporation, who is a close partner of Epigenomics AG, the producer for Epi proColon 2.0 CE.

NCT ID: NCT01383135 Completed - Breast Cancer Clinical Trials

Biodistribution and Safety of the PET Probes [18F]FPRGD2 and [18F]FPPRGD2

Start date: October 2010
Phase: Early Phase 1
Study type: Interventional

The purpose of the study was to conduct a pilot test of new tracers ([18F]FPRGD2 and [18F]FPPRGD2) to define normal tracer biodistribution (where the tracer goes), stability (how much metabolises), pharmacokinetics (how much stays in which organs and for how long), and radiation dosimetry (organ radiation dose). Healthy volunteers provided the normal biodistribution data. The same radiopharmaceutical was also tested in breast cancer, glioblastoma multiform (brain cancer), and lung cancer.